Video

LUGPA 2022: Dr. Shore on the significance of genetic testing in prostate cancer

Author(s):

Urology Times staff
Conference|LUGPA Annual Meeting

“There’s a lot of clinical utility to genetic testing, and there are familial implications and clinical trial implications,” explains Neal Shore, MD.

Neal Shore, MD, explains how genetic testing has become an essential component of the treatment paradigm for patients with prostate cancer. Shore is co-chairing the CME program at the 2022 LUGPA Annual Meeting, which will include a session on genetic testing. Shore is medical director for the Carolina Urologic Research Center and chief medical officer, Surgical Oncology and Urology, for Genesis Care (US).

Related Videos
Mara R. Holton, MD, answers a question during a Zoom video interview
United States Capitol Building | Image Credit: © rrodrickbeiler - stock.adobe.com
Mara R. Holton, MD, answers a question during a Zoom video interview
Dr. Joshua Langston in an interview with Urology Times
Related Content
Conference of doctors | Image Credit: © Aydan - stock.adobe.com
November 15th 2023

Experts highlight Southwest Urology, LUGPA annual meeting

Urology Times staff
"This is the 15th year [of LUGPA,] and I think I've gone maybe 12, 13 years in a row or so, almost every year," says Lawrence Gervasi, MD.
conference of doctors about breast cancer | Image Credit: © Ayden - stock.adobe.com
November 8th 2023

Dr. Goldfischer discusses LUGPA meeting, health policy, and more

Hannah Clarke
"This is our biggest meeting ever in our 15-year history [with] almost 1100 people here," says Evan R. Goldfischer, MD, MBA, FACS.
Urologists strive to personalize active surveillance plans for patients with low-risk prostate cancer
November 4th 2023

Urologists strive to personalize active surveillance plans for patients with low-risk prostate cancer

Ashling Wahner
"Patients shouldn’t be making the decision to do active surveillance without understanding what that means and what their other options are,” one panelist said.
Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
November 3rd 2023

Advanced technology, novel techniques drive use of radiation in prostate cancer

Chris Ryan
“Radiation therapy continues to expand its role, especially if you start talking about [patients with] the ultra high–risk [prostate cancer] or node-positive [disease] and beyond,” says Daniel Spratt, MD.
Expert: AI’s transformative impact can combat burnout crisis in urology
November 3rd 2023

Expert: AI’s transformative impact can combat burnout crisis in urology

Jason M. Broderick
“We went to medical school to take care of patients, not to service the computer, which is what we do for a large part of our daily work," said Inderbir Gill, MD.
Dr. Jayram highlights the latest developments in bladder cancer care
November 3rd 2023

Dr. Jayram highlights the latest developments in bladder cancer care

Ashling Wahner
“There’s a lot of clinical trial activity in the [bladder cancer realm], and hopefully [new therapies will] keep adding to our armamentarium of [treatment strategies] we can offer patients,” said Gautam Jayram, MD.
© 2024 MJH Life Sciences

All rights reserved.